MARKET

TIL

TIL

Instil Bio, Inc.
NASDAQ
19.14
+0.08
+0.42%
Opening 12:12 03/14 EDT
OPEN
19.42
PREV CLOSE
19.06
HIGH
19.50
LOW
18.59
VOLUME
20.52K
TURNOVER
--
52 WEEK HIGH
92.00
52 WEEK LOW
9.62
MARKET CAP
124.91M
P/E (TTM)
-1.6808
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at TIL last week (0303-0307)?
Weekly Report · 4d ago
Instil Bio Non-GAAP EPS of -$1.82
Seeking Alpha · 03/05 15:17
Instil Bio Price Target Maintained With a $110.00/Share by HC Wainwright & Co.
Dow Jones · 03/05 12:22
HC Wainwright & Co. Reiterates Buy on Instil Bio, Maintains $110 Price Target
Benzinga · 03/05 12:12
Instil Bio’s Promising Pipeline and Strategic Collaborations Drive Buy Rating
TipRanks · 03/05 11:39
Instil Bio, Inc. (TIL) Annual Report (Form 10-K) for the fiscal year ended December 31, 2024
Press release · 03/04 23:21
JMP Securities Keeps Their Hold Rating on Instil Bio (TIL)
TipRanks · 03/04 18:26
Instil Bio, Inc. Q4 Loss Declines
NASDAQ · 03/04 12:39
More
About TIL
More
Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first such program is an engineered tumor infiltrating lymphocyte (TIL), cell therapy for the treatment of cancer. It is engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor (CoStAR), platform. The Company's lead CoStAR-TIL product candidate, ITIL-306, expresses a CoStAR molecule designed to recognize folate receptor alpha (Fra), a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC and renal cancer. CAR-T and TCR-T therapies are cell products composed of T cells that have been genetically engineered to recognize a specific cancer-related antigen on the surface of tumor cells.
Recently
Symbol
Price
%Change

Webull offers Instil Bio Inc stock information, including NASDAQ: TIL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TIL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TIL stock methods without spending real money on the virtual paper trading platform.